[Federal Register Volume 84, Number 21 (Thursday, January 31, 2019)]
[Notices]
[Page 756]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00439]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Commission on Childhood Vaccines

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Advisory Commission on Childhood Vaccines (ACCV) has 
scheduled public meetings for the 2019 calendar year (CY). Information 
about ACCV, agendas, and materials for these meetings can be found on 
the ACCV website at: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html.

DATES: ACCV meetings will begin at 10:00 a.m. ET on March 7-8, 2019; 
June 6-7, 2019; September 5-6, 2019; and December 5-6, 2019.

ADDRESSES: Meetings may be held in-person, by teleconference, and/or 
Adobe Connect webinar. In-person ACCV meetings will be held at 5600 
Fishers Lane, Rockville, Maryland 20857. Instructions for joining the 
meetings either in person or remotely will be posted on the ACCV 
website 30 business days before the date of the meeting. For meeting 
information updates, go to the ACCV website meeting page: https://www.hrsa.gov/advisory-committees/vaccines/meetings.html.

FOR FURTHER INFORMATION CONTACT: Annie Herzog, Program Analyst, 
Division of Injury Compensation Programs (DICP), HRSA, 5600 Fishers 
Lane, 08N146B, Rockville, Maryland 20857; 301-443-6593; or 
[email protected].

SUPPLEMENTARY INFORMATION: The ACCV was established by section 2119 of 
the Public Health Service Act (42 U.S.C. 300aa-19), as enacted by 
Public Law (Pub. L.) 99-660, and as subsequently amended, and advises 
the Secretary of HHS (Secretary) on issues related to implementation of 
the National Vaccine Injury Compensation Program (VICP). For CY 2019 
meetings, agenda items may include, but are not limited to, updates 
from DICP, the Department of Justice, the National Vaccine Program 
Office, the Immunization Safety Office, National Institute of Allergy 
and Infectious Diseases, and the Center for Biologics Evaluation and 
Research. Since priorities dictate meeting times, be advised that 
locations and agenda items are subject to change. Refer to the ACCV 
website listed above for all current and updated information concerning 
the CY 2019 ACCV meetings, including draft agendas and meeting 
materials that will be posted before the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting(s). Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to the ACCV should be 
sent to Annie Herzog using the contact information above at least five 
business days before the meeting date(s).
    Individuals who need special assistance or another reasonable 
accommodation should notify Annie Herzog at the address and phone 
number listed above at least 10 business days before the meeting(s) 
they wish to attend. Since all in person meetings will occur in a 
federal government building, attendees must go through a security check 
to enter the building. Non-U.S. Citizen attendees must notify HRSA of 
their planned attendance at least 10 business days prior to the meeting 
in order to facilitate their entry into the building. All attendees are 
required to present government-issued identification prior to entry.

Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2019-00439 Filed 1-30-19; 8:45 am]
 BILLING CODE 4165-15-P